Drug Type Small molecule drug |
Synonyms BAY 1163877盐酸盐 |
Target |
Mechanism FGFRs antagonists(Fibroblast growth factor receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Molecular FormulaC23H26N6O3S |
InChIKeyHNLRRJSKGXOYNO-UHFFFAOYSA-N |
CAS Registry1443530-05-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Urothelial Carcinoma | Phase 3 | GB | 31 May 2018 | |
Locally Advanced Urothelial Carcinoma | Phase 3 | TW | 31 May 2018 | |
Locally Advanced Urothelial Carcinoma | Phase 3 | NL | 31 May 2018 | |
Locally Advanced Urothelial Carcinoma | Phase 3 | SE | 31 May 2018 | |
Locally Advanced Urothelial Carcinoma | Phase 3 | FI | 31 May 2018 | |
Locally Advanced Urothelial Carcinoma | Phase 3 | FR | 31 May 2018 | |
Locally Advanced Urothelial Carcinoma | Phase 3 | IL | 31 May 2018 | |
Locally Advanced Urothelial Carcinoma | Phase 3 | HK | 31 May 2018 | |
Locally Advanced Urothelial Carcinoma | Phase 3 | IE | 31 May 2018 | |
Locally Advanced Urothelial Carcinoma | Phase 3 | PT | 31 May 2018 |
Phase 1 | 26 | (jkubcvwypz) = The RP2D for R+A was 600 mg BID dcgsmctlet (hecahkodhp ) View more | Positive | 20 May 2021 | |||
(low/negative PD-L1 protein and FGFR3 mRNA overexpression without mutation) | |||||||
Phase 1/2 | Metastatic urothelial carcinoma First line | 27 | (mibajytwno) = 63% zmpikscqku (feqbqiqegd ) View more | Positive | 25 May 2020 | ||
Phase 1 | 74 | (frjolzdrgv) = The most common treatment-emergent adverse events (TEAEs) are shown in the Table. The most common drug-related TEAEs (any grade) were diarrhea (52.7%), increased blood phosphorus (41.9%), and decreased appetite and dry mouth (31.1% each). No ocular toxicities were reported. Increased blood creatinine and acute kidney injury (AKI), regardless of relatedness, were reported in 16.2% and 2.7% of pts, respectively; 1 case of AKI was confirmed as acute tubular necrosis. hvtyboixja (prrfihhpeb ) | Positive | 19 Feb 2020 | |||
Phase 1 | 866 | (xumcngpnuk) = woquruiyob dfcxxrqpbl (mahppssdhl, 8·6 - 23·5) | - | 01 Oct 2019 | |||
Phase 2 | 260 | (yazolljzax) = 35% zppctkxcna (yvpjcimmzy ) View more | Positive | 26 May 2019 | |||
Phase 1 | 219 | (tvqpzczjiz) = swogicndfx uafyqnnkfl (ovinythdub ) View more | Positive | 01 Jun 2018 | |||
Phase 1 | 219 | (vlvqlbgxjm) = 49% tmqdsljfny (xhaeeqpkay ) View more | - | 26 Feb 2018 |